Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
Related Questions
How do you approach the use of benzodiazepines in patients with chronic medical illnesses that may be susceptible to respiratory compromise (e.g., CHF, COPD, ILD)?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
Is there a role for nintedanib in the management of patients with radiation-induced pulmonary fibrosis?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
What immunosuppression regimens do clinicians use in patients with progressive RB-ILD despite smoking cessation and prednisone?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
What criteria do you use to determine when to start a steroid-sparing agent for hypersensitivity pneumonitis?
Have you adopted the use of low dose morphine for treatment of cough in patients with IPF?
How long after initiating mycophenolate do you wait before tapering prednisone off in patients with myositis-associated ILD?
What is your approach to evaluation and management of GERD in a patient with IPF?
